Search by PDB author

Human p53 core domain mutant M133L-V203A-Y220C-N239Y-N268D
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2006-08-15
Release date:	2006-09-20
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.65 Å)
Cite:	Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs. Proc.Natl.Acad.Sci.USA, 103, 2006

2J1W

Human p53 core domain mutant M133L-V143A-V203A-N239Y-N268D
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2006-08-15
Release date:	2006-09-20
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs. Proc.Natl.Acad.Sci.USA, 103, 2006

4D1L

Tetramerization domain of zebrafish p53 (crystal form I)
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C.
Deposit date:	2014-05-02
Release date:	2014-08-27
Last modified:	2023-12-20
Method:	X-RAY DIFFRACTION (1.97 Å)
Cite:	Tracing the Evolution of the P53 Tetramerization Domain Structure, 22, 2014

4D1M

Tetramerization domain of zebrafish p53 (crystal form II)
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C.
Deposit date:	2014-05-02
Release date:	2014-08-27
Last modified:	2024-05-08
Method:	X-RAY DIFFRACTION (2.2 Å)
Cite:	Tracing the Evolution of the P53 Tetramerization Domain Structure, 22, 2014

1UOL

Crystal structure of the human p53 core domain mutant M133L/V203A/N239Y/N268D at 1.9 A resolution.
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Allen, M.D, Fersht, A.R.
Deposit date:	2003-09-19
Release date:	2003-10-16
Last modified:	2024-05-08
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Crystal Structure of a Superstable Mutant of Human P53 Core Domain. Insights Into the Mechanism of Rescuing Oncogenic Mutations J.Biol.Chem., 279, 2004

2BIO

human p53 core domain mutant M133L-V203A-N239Y-R249S-N268D
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2005-01-25
Release date:	2005-01-26
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Structures of P53 Cancer Mutants and Mechanism of Rescue by Second-Site Suppressor Mutations J.Biol.Chem., 280, 2005

2BIP

human p53 core domain mutant M133L-H168R-V203A-N239Y-R249S-N268D
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2005-01-25
Release date:	2005-01-26
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Structures of P53 Cancer Mutants and Mechanism of Rescue by Second-Site Suppressor Mutations J.Biol.Chem., 280, 2005

2BIN

human p53 core domain mutant M133L-H168R-V203A-N239Y-N268D
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2005-01-25
Release date:	2005-01-26
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Structures of P53 Cancer Mutants and Mechanism of Rescue by Second-Site Suppressor Mutations J.Biol.Chem., 280, 2005

2BIM

human p53 core domain mutant M133L-V203A-N239Y-N268D-R273H
Descriptor:	CELLULAR TUMOR ANTIGEN P53, SULFATE ION, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2005-01-25
Release date:	2005-01-26
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.98 Å)
Cite:	Structures of P53 Cancer Mutants and Mechanism of Rescue by Second-Site Suppressor Mutations J.Biol.Chem., 280, 2005

2BIQ

human p53 core domain mutant T123A-M133L-H168R-V203A-N239Y-R249S- N268D
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2005-01-25
Release date:	2005-01-26
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Structures of P53 Cancer Mutants and Mechanism of Rescue by Second-Site Suppressor Mutations J.Biol.Chem., 280, 2005

5AOJ

Structure of the p53 cancer mutant Y220C in complex with 2-hydroxy-3, 5-diiodo-4-(1H-pyrrol-1-yl)benzoic acid
Descriptor:	2-hydroxy-3,5-diiodo-4-(1H-pyrrol-1-yl)benzoic acid, CELLULAR TUMOR ANTIGEN P53, DI(HYDROXYETHYL)ETHER, ...
Authors:	Joerger, A.C, Baud, M.G, Bauer, M.R, Fersht, A.R.
Deposit date:	2015-09-10
Release date:	2015-12-16
Last modified:	2024-01-10
Method:	X-RAY DIFFRACTION (1.47 Å)
Cite:	Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53. Structure, 23, 2015

5AOI

Structure of the p53 cancer mutant Y220C in complex with an indole- based small molecule
Descriptor:	2-(5-BROMO-7-ETHYL-2-METHYL-1H-INDOLE-3-YL)ETHAN-1-AMIN, CELLULAR TUMOR ANTIGEN P53, DI(HYDROXYETHYL)ETHER, ...
Authors:	Joerger, A.C, Wilcken, R.
Deposit date:	2015-09-10
Release date:	2015-12-16
Last modified:	2024-01-10
Method:	X-RAY DIFFRACTION (1.78 Å)
Cite:	Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53. Structure, 23, 2015

5AOL

Structure of the p53 cancer mutant Y220C with bound 3-bromo-5-(trifluoromethyl)benzene-1,2-diamine
Descriptor:	3-BROMO-5-(TRIFLUOROMETHYL)BENZENE-1,2-DIAMINE, CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Harbrecht, H.
Deposit date:	2015-09-10
Release date:	2015-12-16
Last modified:	2024-01-10
Method:	X-RAY DIFFRACTION (1.5 Å)
Cite:	Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53. Structure, 23, 2015

5AOK

Structure of the p53 cancer mutant Y220C with bound small molecule PhiKan7099
Descriptor:	5-[2-cyclopropyl-5-(1H-pyrrol-1-yl)-1,3-oxazol-4-yl]-1H-1,2,3,4-tetrazole, CELLULAR TUMOR ANTIGEN P53, DI(HYDROXYETHYL)ETHER, ...
Authors:	Joerger, A.C.
Deposit date:	2015-09-10
Release date:	2015-12-16
Last modified:	2024-01-10
Method:	X-RAY DIFFRACTION (1.35 Å)
Cite:	Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53. Structure, 23, 2015

5AOM

Structure of the p53 cancer mutant Y220C with bound small molecule PhiKan883
Descriptor:	CELLULAR TUMOR ANTIGEN P53, GLYCEROL, N-(5-chloranyl-2-oxidanyl-phenyl)piperidine-4-carboxamide, ...
Authors:	Joerger, A.C, Boeckler, F.M, Wilcken, R.
Deposit date:	2015-09-10
Release date:	2015-12-16
Last modified:	2024-01-10
Method:	X-RAY DIFFRACTION (1.74 Å)
Cite:	Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53. Structure, 23, 2015

5AB9

Structure of the p53 cancer mutant Y220C with bound small molecule 7- ethyl-3-(piperidin-4-yl)-1H-indole
Descriptor:	7-ethyl-3-(piperidin-4-yl)-1H-indole, CELLULAR TUMOR ANTIGEN P53, DI(HYDROXYETHYL)ETHER, ...
Authors:	Joerger, A.C.
Deposit date:	2015-08-04
Release date:	2015-12-16
Last modified:	2024-01-10
Method:	X-RAY DIFFRACTION (1.36 Å)
Cite:	Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53. Structure, 23, 2015

5ABA

Structure of the p53 cancer mutant Y220C with bound small-molecule stabilizer PhiKan5149
Descriptor:	1-{1-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl piperidin-4-yl}piperidin-4-ol], CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C.
Deposit date:	2015-08-04
Release date:	2015-12-16
Last modified:	2024-01-10
Method:	X-RAY DIFFRACTION (1.62 Å)
Cite:	Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53. Structure, 23, 2015

2J21

Human p53 core domain mutant M133L-V203A-N239Y-N268D-R282W
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2006-08-15
Release date:	2006-09-20
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.6 Å)
Cite:	Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs. Proc.Natl.Acad.Sci.USA, 103, 2006

2J1Y

Human p53 core domain mutant M133L-V203A-N239Y-G245S-N268D
Descriptor:	CALCIUM ION, CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2006-08-15
Release date:	2006-09-20
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.69 Å)
Cite:	Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs. Proc.Natl.Acad.Sci.USA, 103, 2006

2J20

Human p53 core domain mutant M133L-V203A-N239Y-N268D-R273C
Descriptor:	CELLULAR TUMOR ANTIGEN P53, SULFATE ION, ZINC ION
Authors:	Joerger, A.C, Ang, H.C, Fersht, A.R.
Deposit date:	2006-08-15
Release date:	2006-09-20
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs. Proc.Natl.Acad.Sci.USA, 103, 2006

2J1Z

Human p53 core domain mutant M133L-V203A-N239Y-N268D-F270L
Descriptor:	CELLULAR TUMOR ANTIGEN P53, ZINC ION
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2006-08-15
Release date:	2006-09-20
Last modified:	2023-12-13
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs. Proc.Natl.Acad.Sci.USA, 103, 2006

2WQJ

Crystal structure of a truncated variant of the human p73 tetramerization domain
Descriptor:	TUMOR PROTEIN P73
Authors:	Joerger, A.C.
Deposit date:	2009-08-21
Release date:	2009-10-06
Last modified:	2024-05-08
Method:	X-RAY DIFFRACTION (2 Å)
Cite:	Structural Evolution of P53, P63, and P73: Implication for Heterotetramer Formation. Proc.Natl.Acad.Sci.USA, 106, 2009

2WQI

Crystal structure of the human p73 tetramerization domain
Descriptor:	TUMOR PROTEIN P73
Authors:	Joerger, A.C.
Deposit date:	2009-08-21
Release date:	2009-10-06
Last modified:	2024-05-08
Method:	X-RAY DIFFRACTION (1.7 Å)
Cite:	Structural Evolution of P53, P63, and P73: Implication for Heterotetramer Formation. Proc.Natl.Acad.Sci.USA, 106, 2009

2WTT

Structure of the human p73 tetramerization domain (crystal form II)
Descriptor:	TUMOR PROTEIN P73
Authors:	Joerger, A.C.
Deposit date:	2009-09-21
Release date:	2009-10-13
Last modified:	2024-10-23
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	Structural Evolution of P53, P63, and P73: Implication for Heterotetramer Formation. Proc.Natl.Acad.Sci.USA, 106, 2009

1HL2

Crystal structure of N-acetylneuraminate lyase from E. coli mutant L142R in complex with b-hydroxypyruvate
Descriptor:	3-HYDROXYPYRUVIC ACID, N-ACETYLNEURAMINATE LYASE SUBUNIT
Authors:	Joerger, A.C, Fersht, A.R.
Deposit date:	2003-03-12
Release date:	2003-05-09
Last modified:	2024-11-06
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Mimicking Natural Evolution in Vitro: An N-Acetylneuraminate Lyase Mutant with an Increased Dihydrodipicolinate Synthase Activity Proc.Natl.Acad.Sci.USA, 100, 2003

12 3 4 5 6 7 >

Total results:	156
Displayed results:	25
Sorted by:	Hit score (from highest)